Metahexamide (INN) is an anti-diabetic drug from the group of sulfonylureas.

It is long-acting and belongs to the first-generation cyclohexyl-containing sulfonylureas.

It was first described in 1959.

[1] This drug article relating to the gastrointestinal system is a stub.

You can help Wikipedia by expanding it.